glp-1 aspiration Endoscopy & Receptor Agonists GLP-1 and Anesthesia: Considerations and
Description
BMI 25 to 30 (overweight) People starting in the overweight range can expect moderate but meaningful weight loss
1999;276(1 pt 1):G79G91
The has approved GLP-1 injections for individuals with a BMI of 30 or higher or a BMI of 27 with obesity-related health conditions such as diabetes or high blood pressure
For example, Ozempic and Wegovy are injected weekly, and the dose is adjusted based on tolerance
GLP-1 receptor agonists mimic endogenous incretin hormones to regulate glucose levels and induce satiety
Luli, M
